This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Pick These 4 Stocks With Solid Interest Coverage Ratio
by Sumit Singh
STRL, LDOS, THC & AMZN's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Encompass Health Up 60% in a Year: What Lies Ahead for Investors?
by Zacks Equity Research
EHC remains well-poised for growth on the back of solid discharge growth, an aging U.S. population, frequent expansion initiatives and strong cash reserves.
Why Is Tenet (THC) Down 10.2% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Retaining Cigna Stock is a Smart Move for Investors Now
by Zacks Equity Research
CI is well-poised for growth on the back of strong contributions from the Evernorth and Cigna Healthcare units. A strong financial position enables it to undertake business investments.
Is Tenet Healthcare (THC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teladoc Enhances Virtual Sitter With AI for Improved Care Delivery
by Zacks Equity Research
TDOC's upgraded Virtual Sitter uses AI to prevent patient falls, boost staff efficiency and enhance care delivery, thus addressing major challenges in hospitals and health systems.
Is It Worth Investing in Tenet (THC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Tenet (THC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Community Health to Sell Florida Hospital to AdventHealth for $265M
by Zacks Equity Research
CYH enters an agreement to sell ShorePoint Health System assets in Florida for $265 million, advancing its strategy to shed non-core facilities and enhance focus on growth areas.
Wall Street Analysts See a 30.38% Upside in Tenet (THC): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Tenet (THC) points to a 30.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
How to Find Strong Buy Medical Stocks Using the Zacks Rank
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Zacks Value Trader Highlights: Dream Finders Homes, Tenet Healthcare, El Pollo Loco, The Greenbrier Companies and Pediatrix Medical
by Zacks Equity Research
Dream Finders Homes, Tenet Healthcare, El Pollo Loco, The Greenbrier Companies and Pediatrix Medical have been highlighted in this Value Trader article.
5 Cheap Strong Buy Stocks: Values or Traps?
by Tracey Ryniec
These stocks have low P/E and P/S ratios and are Zacks Rank #1 (Strong Buys). But are they true values?
2 Small Cap AI Revolution Stocks for Your Watch List
by Tracey Ryniec
What are the risks, and rewards, of looking beyond NVIDIA and Super Micro Computer in the AI trade?
Acadia Healthcare Stock Closer to 52-Week Low: A Buying Opportunity?
by Zacks Equity Research
ACHC is facing significant challenges, including lower returns, rising costs and declining free cash flow.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store.
Tenet Healthcare Partners With Commure for Ambient AI Platform
by Zacks Equity Research
THC actively invests in selected AI-enabled technologies, which are expected to enhance the clinical and administrative workflow and efficiency.
Brookdale Q3 Earnings Miss on Marketing Cost Hike, Shares Decline 18%
by Zacks Equity Research
BKD's Q3 results reflect higher marketing costs and lower interest income. Revenues and other operating income improve 3.5% year over year, driven by increased occupancy and RevPOR.
Pick These 4 Stocks With Solid Interest Coverage Ratio
by Sumit Singh
STRL, LDOS, THC & AMZN's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal
by Zacks Equity Research
The DOJ suggests that UNH's acquisitions reflect a strategy of buying competitors rather than competing directly, potentially giving it control over multiple markets.
Cigna Ends Humana Merger Speculation: CI Jumps 7.3% While HUM Slips
by Zacks Equity Research
CI reaffirms its 2024 outlook, projecting full-year adjusted EPS to be a minimum of $28.40.
Should Vanguard S&P Mid-Cap 400 Value ETF (IVOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOV
Zacks Industry Outlook HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
5 Hospital Stocks Set to Thrive Amid Robust Industry Trends
by Zacks Equity Research
The Zacks Medical-Hospital industry is likely to gain from rising patient admissions and technological advancements. Companies like HCA, THC, UHS, ACHC and CYH are poised to gain from these trends.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.